Iodide

Iodide

SCHEMBL1316828

CCCCCCCCCCCCOCC(COCCCCCCCCCCCC)(COCC[N+](C)(C)C)COCC[N+](C)(C)C.[I-].[I-]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKD3 O94806 2/20 0.56
PRKCG P05129 2/20 0.56
PRKCB P05771 2/20 0.56
PRKCA P17252 2/20 0.56
PRKCH P24723 2/20 0.56
PRKCI P41743 2/20 0.56
PRKCE Q02156 2/20 0.56
PRKCQ Q04759 2/20 0.56
PRKCZ Q05513 2/20 0.56
PRKCD Q05655 2/20 0.56
PRKD1 Q15139 2/20 0.56
DNM1 Q05193 6/20 0.48
LMNA P02545 2/20 0.45
AKT1 P31749 2/20 0.45
ESR1 P03372 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
CDC25A P30304 1/20 0.45
AGTR1 P30556 1/20 0.45
ADRA1A P35348 1/20 0.45
KCNH2 Q12809 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL1316451 1.00 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
Iodide SCHEMBL1321524 1.00 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
Iodide SCHEMBL1320407 1.00 PRKD3 (0.56) PRKD3PRKCGPRKCBPRKCAPRKCH
Iodide SCHEMBL1318070 0.93 DNM1 (0.54) PRKD3PRKCGPRKCBPRKCAPRKCH
Iodide SCHEMBL1319138 0.93 DNM1 (0.54) PRKD3PRKCGPRKCBPRKCAPRKCH
Iodide SCHEMBL1320847 0.93 DNM1 (0.54) PRKD3PRKCGPRKCBPRKCAPRKCH
Iodide SCHEMBL1316964 0.89 DNM1 (0.48) PRKD3PRKCGPRKCBPRKCAPRKCH
Iodide SCHEMBL1317693 0.89 DNM1 (0.48) PRKD3PRKCGPRKCBPRKCAPRKCH
Iodide SCHEMBL1318941 0.89 DNM1 (0.48) PRKD3PRKCGPRKCBPRKCAPRKCH
Iodide SCHEMBL1319650 0.89 DNM1 (0.48) PRKD3PRKCGPRKCBPRKCAPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110269652-A1 GEMINI SURFACTANTS ST. FRANCIS XAVIER UNIVERSITY (CA) 2011-11-03 US disclosed
EP-2349978-A1 GEMINI SURFACTANTS St. Francis Xavier University (CA) 2011-08-03 EP disclosed
WO-2010048715-A1 GEMINI SURFACTANTS ST. FRANCIS XAVIER UNIVERSITY (CA) 2010-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269652-A1 GEMINI SURFACTANTS SGMS1, DEGS1, GMNN PRKD3 3017/4885PRKCG 2838/4885PRKCB 3643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.